Internal Medicine, Nephrology · Greenbelt, MD
NPI
1215164298
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7500 Greenway Center Dr, Ste. 930
Greenbelt, MD, 20770
Phone (301) 345-2412
Groups this clinician bills Medicare through
Medicare paid, 2024
$325K
3,063 services
Medicare patients, 2024
547
Average age 74
Drug cost, 2024
$247K
1,180 prescriptions
Company payments, 2025
$1,245
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vishwam R Pandya was code 99232 (hospital e&m - subsequent), 1,140 times for 267 patients. In total Vishwam R Pandya billed 3,063 services in 18 codes, and Medicare paid $325K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,140 | 267 | $69.98 | $80K |
| 99214 Office E&M - Established | Office | 364 | 183 | $62.14 | $23K |
| 90960 ESRD Related Services (not dialysis) | Office | 327 | 51 | $330.99 | $108K |
| 99222 Hospital E&M - Initial | Facility | 211 | 194 | $114.84 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 197 | 113 | $14.70 | $2,896 |
| 90966 ESRD Related Services (not dialysis) | Office | 132 | 18 | $276.05 | $36K |
| 90961 ESRD Related Services (not dialysis) | Office | 121 | 47 | $275.77 | $33K |
| 90962 ESRD Related Services (not dialysis) | Office | 32 | 17 | $191.06 | $6,114 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 28 | $44.14 | $1,280 |
| 99204 Office E&M - New | Office | 27 | 27 | $138.35 | $3,735 |
| 99213 Office E&M - Established | Office | 14 | 14 | $78.33 | $1,097 |
By year: 2022 $394K for 3,610 services; 2023 $385K for 3,443 services; 2024 $325K for 3,063 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vishwam R Pandya prescribed most often to Medicare patients was Clinisol (Parenteral Amino Acid 15% No.5), with 94 prescriptions and refills. In total Vishwam R Pandya wrote 1,180 Medicare prescriptions that cost $247K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clinisol Parenteral Amino Acid 15% No.5 | 94 | 94 | Under 11 | $13K |
| Calcitriol Generic | 85 | 166 | 22 | $1,423 |
| Losartan Potassium Generic | 84 | 184 | 26 | $648 |
| Amlodipine Besylate Generic | 64 | 130 | 19 | $486 |
| Prosol Parenteral Amino Acid 20% No.1 | 62 | 62 | Under 11 | $15K |
| Furosemide Generic | 60 | 127 | 18 | $285 |
| Lisinopril Generic | 55 | 111 | 14 | $219 |
| Farxiga Dapagliflozin Propanediol | 52 | 72 | 14 | $38K |
| Jardiance Empagliflozin | 49 | 57 | Under 11 | $33K |
| Metoprolol Succinate Generic | 44 | 104 | 15 | $474 |
| Calcium Acetate Generic | 37 | 83 | 16 | $2,390 |
| Gentamicin Sulfate Generic | 33 | 36 | Under 11 | $1,217 |
| Hydralazine Hcl Generic | 32 | 86 | 11 | $711 |
| Sevelamer Carbonate Generic | 32 | 72 | 14 | $6,387 |
| Veltassa Patiromer Calcium Sorbitex | 31 | 41 | Under 11 | $31K |
Brand drugs: 262 claims; generic drugs: 918 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vishwam R Pandya $1,245 ($1,245 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $165.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $133 |
| Scpharmaceuticals Inc. SCPH | 4 | $116 |
| Vifor Pharma, Inc. | 4 | $107 |
| Akebia Therapeutics Inc AKBA | 4 | $97.91 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $89.26 |
| Amgen Inc. AMGN | 4 | $86 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $71.75 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $66.03 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $56.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.